Biomay and Synthego Partner on Integrated cGMP CRISPR Manufacturing
- Biomay will resell its mRNA, LNP formulation, aseptic fill-finish, plasmid DNA, recombinant proteins, and Cas9 production services to Synthego customers across North America.
- The collaboration provides integrated cGMP solutions combining Biomay's manufacturing capabilities with Synthego's sgRNA design and manufacturing expertise for gene-editing therapies.
- Synthego customers gain access to Biomay's off-the-shelf and cGMP Cas9 products, plus custom mRNA manufacturing and fill-finish services for CRISPR programs.
Operational Impact
Biomay expands its CDMO service reach by embedding its cGMP mRNA, LNP, fill-finish, and Cas9 manufacturing into Synthego's customer base, accelerating access to integrated gene-editing manufacturing for clinical-stage programs.
Source: Contract Pharma Breaking News RSS